Literature DB >> 8511912

Preparation of the intensive care patient for major surgery.

B M Wolfe1, P G Moore.   

Abstract

Improved methods for monitoring and treating critically ill patients have increased the number of surgical candidates with multiorgan system impairment. Whereas such patients may have been considered "too sick to undergo surgery" in the past, many such patients linger in the intensive care unit unless definitive therapy is accomplished. Specific attention to review of the patient's preoperative preparation for surgery on a system-by-system basis may improve outcome substantially. The need for possible mechanical ventilation prior to transport to the operating room must receive particular attention. Pneumothorax, if present, must be treated prior to institution of positive-pressure ventilation so progression to tension pneumothorax can be avoided. Deficits in the circulating blood volume must be identified and corrected preoperatively if possible. A need for enhancement of cardiac output or alteration of vascular tone requires pulmonary arterial catheterization and indicates an increased operative risk. Metabolic abnormalities such as disturbances of acid-base balance, sodium or potassium concentration, and endocrinopathies are identified and corrected as much as possible prior to operation. Antibiotics are instituted as appropriate. Replacement of the red blood cell mass is dictated primarily by anticipated or actual blood loss. Factors of coagulation are infused on a replacement basis as necessary. Great care must be taken during transport to the operating room, as maintenance of intravascular monitoring devices, therapeutic infusions, and mechanical ventilation must continue during transport. Precautions must be taken to avoid hypothermia during transport and institution of anesthesia. Critical illness mandates specific considerations of the anesthetic agents to be utilized.

Entities:  

Mesh:

Year:  1993        PMID: 8511912     DOI: 10.1007/BF01658925

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  25 in total

1.  Differential diagnosis and treatment of oliguria in post-traumatic and postoperative patients.

Authors:  R A Danielson
Journal:  Surg Clin North Am       Date:  1975-06       Impact factor: 2.741

2.  THE CARDIAC OUTPUT IN PATIENTS WITH CHRONIC ANEMIA AS MEASURED BY THE TECHNIQUE OF RIGHT ATRIAL CATHETERIZATION.

Authors:  E S Brannon; A J Merrill; J V Warren; E A Stead
Journal:  J Clin Invest       Date:  1945-05       Impact factor: 14.808

3.  Toward a basic understanding of diabetic complications.

Authors:  M W Steffes; S M Mauer
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

4.  Perioperative total parenteral nutrition in surgical patients.

Authors: 
Journal:  N Engl J Med       Date:  1991-08-22       Impact factor: 91.245

5.  Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis.

Authors:  R D Hull; G E Raskob; J Hirsh; R M Jay; J R Leclerc; W H Geerts; D Rosenbloom; D L Sackett; C Anderson; L Harrison
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

Review 6.  Thyroid emergencies.

Authors:  R Hoffenberg
Journal:  Clin Endocrinol Metab       Date:  1980-11

7.  The influence of sepsis and multisystem and organ failure on mortality in the surgical intensive care unit.

Authors:  L Manship; R D McMillin; J J Brown
Journal:  Am Surg       Date:  1984-02       Impact factor: 0.688

8.  Anaemia and surgery.

Authors:  J N Lunn; P C Elwood
Journal:  Br Med J       Date:  1970-07-11

9.  Relation between skin cancer and HLA antigens in renal-transplant recipients.

Authors:  J N Bouwes Bavinck; B J Vermeer; F J van der Woude; J P Vandenbroucke; G M Schreuder; J Thorogood; G G Persijn; F H Claas
Journal:  N Engl J Med       Date:  1991-09-19       Impact factor: 91.245

Review 10.  Cardiac risks and complications of noncardiac surgery.

Authors:  L Goldman
Journal:  Ann Intern Med       Date:  1983-04       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.